[Hepatitis C]

Area of Science:

• Hepatology
• Virology
• Infectious Diseases

Background:

• Hepatitis C virus (HCV) infection is a major global cause of chronic liver disease, liver cirrhosis, and hepatocellular carcinoma.
• Understanding HCV's virology, diagnosis, and treatment is crucial for managing patient outcomes.

Purpose of the Study:

• To provide a concise review of the virology, diagnosis, and current therapy for Hepatitis C virus infection.
• To highlight recent advancements in identifying novel antiviral targets and therapeutic strategies.

Main Methods:

• Review of existing literature on Hepatitis C virus (HCV).
• Analysis of standard therapy efficacy based on patient genotypes.
• Exploration of emerging antiviral targets and treatment approaches.

Main Results:

• Standard therapy with pegylated interferon-alpha and ribavirin achieves sustained virological response in 40-50% of genotype 1 patients.
• Approximately 80% of genotype 2 or 3 infected patients achieve sustained virological response with standard therapy.
• Novel antiviral targets and therapeutic strategies have been identified.

Conclusions:

• Current standard therapies for Hepatitis C virus have variable efficacy depending on genotype.
• Recent progress in antiviral research offers potential for improved future treatments.
• New therapeutic strategies are expected to complement existing modalities for Hepatitis C management.